These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma. Leung AK; Chow SM; Law SC Laryngoscope; 2008 Jan; 118(1):32-8. PubMed ID: 18025951 [TBL] [Abstract][Full Text] [Related]
26. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer. Seaberg RM; Eski S; Freeman JL Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356 [TBL] [Abstract][Full Text] [Related]
29. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Lam AK; Lo CY Ann Surg Oncol; 2006 Feb; 13(2):176-81. PubMed ID: 16411146 [TBL] [Abstract][Full Text] [Related]
30. Treatment for microcarcinoma of the thyroid--clinical experience. Küçük NO; Tari P; Tokmak E; Aras G Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573 [TBL] [Abstract][Full Text] [Related]
31. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Ivanova R; Soares P; Castro P; Sobrinho-Simões M Virchows Arch; 2002 Apr; 440(4):418-24. PubMed ID: 11956824 [TBL] [Abstract][Full Text] [Related]
32. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460 [TBL] [Abstract][Full Text] [Related]
33. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553 [TBL] [Abstract][Full Text] [Related]
34. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907 [TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution. Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082 [TBL] [Abstract][Full Text] [Related]
37. High recurrent rate of multicentric papillary thyroid carcinoma. Lin JD; Chao TC; Hsueh C; Kuo SF Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244 [TBL] [Abstract][Full Text] [Related]
38. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival. Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932 [TBL] [Abstract][Full Text] [Related]
39. Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Machens A; Hauptmann S; Dralle H Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243 [TBL] [Abstract][Full Text] [Related]
40. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases]. Liu WS; Qi YF; Tang PZ Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]